1. Home
  2. LCLN vs WVE Comparison

LCLN vs WVE Comparison

Compare LCLN & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lincoln International Inc. Class A Common Stock

LCLN

Lincoln International Inc. Class A Common Stock

HOLD

Current Price

$23.67

Market Cap

821.7M

Sector

Finance

ML Signal

HOLD

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$3.18

Market Cap

673.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LCLN
WVE
Founded
1996
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
821.7M
673.9M
IPO Year
2026
2015

Fundamental Metrics

Financial Performance
Metric
LCLN
WVE
Price
$23.67
$3.18
Analyst Decision
Buy
Strong Buy
Analyst Count
7
21
Target Price
★ $27.07
$17.22
AVG Volume (30 Days)
342.2K
★ 2.9M
Earning Date
11-05-2026
10-27-2026
Dividend Yield
★ 1.14%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $3,704,000.00
Revenue This Year
$28.20
$19.15
Revenue Next Year
$15.26
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 149.43
52 Week Low
$20.05
$3.04
52 Week High
$27.55
$21.73

Technical Indicators

Market Signals
Indicator
LCLN
WVE
Relative Strength Index (RSI) 45.12 32.54
Support Level $22.81 $3.04
Resistance Level $23.75 $4.07
Average True Range (ATR) 0.87 0.17
MACD 0.02 0.05
Stochastic Oscillator 24.10 18.72

Price Performance

Historical Comparison
LCLN
WVE

About LCLN Lincoln International Inc. Class A Common Stock

Lincoln International Inc is an independent investment banking advisory company focused on private capital markets. The company operates its business through its two operating segments: Investment Banking Advisory and Valuations and Opinions. The Investment Banking Advisory segment offers a range of services related to mergers and acquisitions, with key areas of focus including sell-side advisory, buy-side advisory, asset sales and divestitures, restructuring, primary and secondary capital raising, and merger-related engagements. The Valuations and Opinions segment provides valuation services to investment funds and financial institutions. The majority of revenue is derived from the Investment Banking Advisory segment. Geographically, the maximum revenue is derived from the Americas.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Inc is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: